Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.
暂无分享,去创建一个
Cheng Cheng | Dario Campana | Ching-Hon Pui | Melissa M Hudson | Deqing Pei | J. Downing | F. Behm | S. Raimondi | M. Relling | Cheng Cheng | D. Campana | C. Pui | W. Evans | M. Hudson | R. Ribeiro | D. Pei | J. Rubnitz | S. Howard | G. Rivera | J. Sandlund | Mary V Relling | James R Downing | Susana C Raimondi | William E Evans | Raul C Ribeiro | Jeffrey E Rubnitz | Larry E Kun | B. Razzouk | John T Sandlund | L. Kun | Scott C Howard | Bassem I Razzouk | Frederick G Behm | Gaston K Rivera | Deqing Pei
[1] C. Pui. Toward optimal central nervous system-directed treatment in childhood acute lymphoblastic leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] J. Downing,et al. Results of therapy for acute lymphoblastic leukemia in black and white children. , 2003, JAMA.
[3] B. Gallie,et al. Retinoblastoma with central retinal artery thrombosis that mimics extraocular disease. , 2002, Medical and pediatric oncology.
[4] M. Relling,et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. , 2003, The New England journal of medicine.
[5] H. Cavé,et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report , 2000, Leukemia.
[6] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .
[7] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[8] W. Hiddemann,et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. , 2000, Blood.
[9] Cheng Cheng,et al. Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemia. , 2002, JAMA.
[10] S. Shurtleff,et al. Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] N. Winick,et al. A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial , 2001, Leukemia.
[12] M. Relling,et al. De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivo. , 2002, Blood.
[13] C. Pui,et al. Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop , 2004, Leukemia.
[14] J. Downing,et al. Satelite Symposium V, Meet-the-Professor Sessions I and II, Main Sessions I-IX , 2004, Annals of Hematology.
[15] M. Amylon,et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study , 1999, Leukemia.
[16] F. Behm,et al. L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins. , 1995, Leukemia.
[17] M. Relling,et al. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up‐front treatment of acute lymphoblastic leukemia , 2003, Clinical pharmacology and therapeutics.
[18] D. Campana,et al. New definition of remission in childhood acute lymphoblastic leukemia , 2000, Leukemia.
[19] M. Schrappe,et al. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] M. Relling,et al. TOPOISOMERASE II INHIBITOR‐RELATED ACUTE MYELOID LEUKAEMIA , 2000, British journal of haematology.
[21] C. Pui,et al. Acute lymphoblastic leukemia. , 1998, The New England journal of medicine.
[22] K. Ciesielski,et al. Visual and verbal short-term memory deficits in childhood leukemia survivors after intrathecal chemotherapy. , 1997, Journal of pediatric psychology.
[23] D. Cavouras,et al. Quantitative assessment of cerebral atrophy during and after treatment in children with acute lymphoblastic leukemia. , 1996, Investigative radiology.
[24] F. Behm,et al. Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. , 2002, Blood.
[25] M. Relling,et al. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. , 2000, Blood.
[26] Wan Ariffin Bin Abdullah,et al. Med Pediatr Oncol , 1999 .
[27] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .
[28] N. Heerema,et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 2003, Blood.
[29] F. Behm,et al. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. , 1993, The New England journal of medicine.
[30] M. Schrappe,et al. Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] D. Campana,et al. Childhood acute lymphoblastic leukaemia--current status and future perspectives. , 2001, The Lancet. Oncology.
[32] J. Downing,et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.
[33] Laurence L. George,et al. The Statistical Analysis of Failure Time Data , 2003, Technometrics.
[34] F. Behm,et al. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. , 1998, Blood.
[35] S. Sallan,et al. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. , 2000, Journal of pediatric hematology/oncology.
[36] R. Gelber,et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. , 2001, Blood.
[37] D. Campana. Determination of minimal residual disease in leukaemia patients , 2003, British journal of haematology.
[38] W. Bleyer,et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995 , 2000, Leukemia.